Drug Transporter (DT) Information

General Information of DT
DT ID DTD0111
Gene Name SLC16A7
Protein Name Monocarboxylate transporter 2
Gene ID
9194
UniProt ID
O60669
TCDB ID
2.A.1.13.5
3D Structure

Modelled DT Structure

Method: loop building

Template PDB: 7BP3_A

Identity: 100%

Minimized Score: -984.428 kcal/mol

Detail: Structure Info

Synonyms Solute carrier family 16 member 7; MCT 2; SLC16A7; MCT2
DT Family Major Facilitator Superfamily (MFS)
Monocarboxylate Transporter (MCT) Family
Tissue Specificity Detected in heart and in blood lymphocytes and monocytes (at protein level). High expression in testis, moderate to low in spleen, heart, kidney, pancreas, skeletal muscle, brain and Leukocyte. Restricted expression in normal tissues, but widely expressed in cancer cells.
Function This transporter functions as high-affinity pyruvate transporter, and this proton-coupled monocarboxylate transporter can catalyzes the rapid transport across the plasma membrane of many monocarboxylates such as lactate, pyruvate, branched-chain oxo acids derived from leucine, valine and isoleucine, and the ketone bodies acetoacetate, beta-hydroxybutyrate and acetate.
Disease(s) Epilepsy [ICD-11: 8A6Z]
Obesity [ICD-11: 5B81]
Pain [ICD-11: MG30-MG7Z]
Heart attack [ICD-11: BA41.Z]
Endogenous Substrate(s) Monocarboxylates; Gamma-hydroxybutyrate
Variability Data of This Drug Transporter (DT)

Regulatory Variability Data of This DT (VARIDT 3.0)

(α) Microbiota Influence of This DT
Microbiota Influence (MBI)

(β) Post-translational Modification of This DT
Post-translational Modification (PTM)

(γ) Transcriptional Regulation of This DT
Transcriptional Regulation (TSR)

(δ) Epigenetic Regulation of This DT
Epigenetic Regulation (EGR)

(ε) Exogenous Modulation of This DT
Exogenous Modulation (EGM)

Structural Variability Data of This DT (VARIDT 2.0)

(α) Mutation-induced Structural Variation
Mutation-induced Structural Variation (MSV)

(β) Inter-species Structural Differences
Inter-species Structural Differences (ISD)

(γ) Outward/inward-facing Conformation
Outward/inward-facing Conformation (OIC)

(δ) Xenobiotics-regulated Structural Variability
Xenobiotics-regulated Structural Variability (XSV)

General Variability Data of This DT (VARIDT 1.0)

(α) Genetic Polymorphisms of This DT
Genetic Polymorphisms of This DT (GPD)

(β) Disease-specific Protein Abundances of This DT
Disease-specific Protein Abundances of This DT (DPAD)

(γ) Species- and Tissue-specific DT Abundances
Species/Tissue-specific Protein Abundances of This DT (S/TPAD)
Molecular Transporting Profile of This DT

Full List of Drug(s) Transported by This DT

 Approved Drug

 Click to Show/Hide the Full List of Drug:            5 Drugs in Total
Drug Name Highest Status Detail Indication ICD 11 Ref
Atorvastatin
 Approved Drug Info Hyperlipidaemia 5C8Z [1]
Ibuprofen
 Approved Drug Info Pain MG30-MG7Z [1]
Propicillin
 Approved Drug Info Streptococcus bacterial infections 1C41 [1]
Salicylic acid
 Approved Drug Info Dermatitis EA80-EA8Z [2]
Valproic Acid
 Approved Drug Info Epilepsy 8A6Z [1]

 Phase 3 Drug

 Click to Show/Hide the Full List of Drug:            1 Drugs in Total
Drug Name Highest Status Detail Indication ICD 11 Ref
Quercetin
 Phase 3 Drug Info Coronary artery disease BA6Z [1]

Drug-DT Affinity Assessed by Cell Line

 Investigative Drug

 Click to Show/Hide the Full List of Drug:            1 Drugs in Total
Drug Name Highest Status Detail Cell Line Affinity Ref
Milchsaure Investigative Drug Info Oocytes-MCT2 Km = 6.5 microM [3]
References
1 Monocarboxylate Transporters in Drug Disposition: Role in the Toxicokinetics and Toxicodynamics of the Drug of Abuse GHB.
2 Clinical and Functional Relevance of the Monocarboxylate Transporter Family in Disease Pathophysiology and Drug Therapy. Clin Transl Sci. 2018 Jul;11(4):352-364.
3 Human monocarboxylate transporter 2 (MCT2) is a high affinity pyruvate transporter. J Biol Chem. 1998 Oct 30;273(44):28959-65.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.